TrialEuropean radiology2022

Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.

Yanbo Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.